4
46
Growth Score
-5 pts
Heat Score
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
340100
NaNotics is developing an advanced nanomedical platform for treating major diseases in humans and their companion animals.
- Curtis Ruegg: CDO/COOPast Role: Amphivena Therapeutics, President and CEO
- Lou Hawthorne: Co-Founder and CEO
About the Company
NaNotics is a medical platform created to treat autoimmune disorders and solid tumor malignancies. The business's platform comprises extractors that eliminate particular circulating molecular signals or signal inhibitors that promote or facilitate illness progression, allowing doctors to provide patients with a potent new and extremely safe
mode of disease treatment.
